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1. Introduction 
Epinephrine treatment of the perfused rat heart 
leads to the activation of phosphofructokinase (PFK) 
via an a-adrenergic receptor mechanism, independent 
of changes in the intracellular concentration of cyclic 
AMP [ 1 ]. The activation is characterized by a loss in 
sensitivity to the inhibitors, ATP [ 1 ] and citrate [2], 
and is stable to gel-filtration [2,3]. Reconversion of 
the activated form to the non-activated form is cata- 
lyzed in heart extracts but does not appear to involve 
phosphoprotein phosphatase [2]. Here, the enzyme 
assay from [ 1,4] and SDS-polyacrylamide g l elec- 
trophoresis of immunoprecipitates of PFK were used 
to examine the relationship between c~-receptor- 
mediated activation and phosphorylation. 
5 vol. 100 mM Tris-HC1 (pH 7.4) containing 1mM 
dithiothreitol, 100 mM phosphate and 30 mM NaF. 
Supernatants (100 000 × g for 15 min) were mixed 
with an equal volume of reconstituted antiserum 
(100 mg/ml Tris-HCl-dithiothreitol) and allowed to 
stand at 4°C for 17 h. Immunoprecipitates (8000 × g 
for 10 min) were washed twice with isotonic saline 
and solubilized by incubation for 10 min at 95°C in 
200/21 63 mM Tris-HC1 (pH 7.0), 1% SDS, 2.5% 
2-mercaptoethanol, 5% glycerol and 0.02% bromo- 
phenol blue. Electrophoresis on 6% gels (10 cm) was 
done as in [8]. The specific radioactivity of [,),.32p]. 
ATP in heart powders was determined as in [9]. The 
activity ratio of PFK [ 1 ] was determined in hearts to 
which [32p] phosphate had not been added. Other 
experimental details were as in [ 1,3,4]. 
2. Materials and methods 3. Results 
i~abbit skeletal muscle PFK (Sigma, 185 units/mg) 
was labelled with 14C by using iodo [2-14C] acetic acid. 
The reaction mixture contained 100/ag salt-free PFK 
and 1 mM iodo [2-14C]acetic acid (4 #Ci) in 0.6 ml 
100 mM Tris-HC1 (pH 7.4). After 3 h at 30°C 2 mM 
dithiothreitol was added to stop the reaction. The 
resulting specific radioactivity was ~500 cpm//ag PFK. 
Goat antiserum to rabbit skeletal muscle PFK was 
prepared, fractionated and stored as a powder at 
-20°C [5,6]. Hearts were perfused with low-phos- 
phate medium containing [32p]phosphate (0.1 mCi/ml 
for 30 min) [7], agonists were present for 5 min, then 
the hearts were freeze-clamped in liquid N2-cooled 
tongs. Frozen heart powders were homogenized in 
* To whom correspondence should be addressed 
Goat antiserum to rabbit skeletal muscle PFK was 
found to inactivate control and epinephrine-activated 
PFK in heart extracts (fig.l). Each form reacted in a 
similar manner; ~20 t21 (2.0 mg) of antiserum inacti- 
vated all of the enzyme activity in 100 #1 1:5 heart 
extract. Densitometric s ans of the stained PFK 
(band II, fig.2) on the polyacrylamide g ls indicated 
that the amount of antiserum required to precipitate 
all of the PFK in 100/al extract was ~20 mg or 
10-fold that required to inactivate the enzyme. Serum 
from non-immunized goats did not inactivate PFK. 
SDS-Polyacrylamide g ls of the rabbit skeletal 
muscle PFK indicated several minor contaminants 
(fig.2). Phosphorylase was one of these and thus 
immunoprecipitates from [a2P]phosphate.labelled 
extracts contained significant radioactivity in the 
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region of the phosphorylase ubunit (band I, fig.2; 
~95 000 Mr). Antiserum to PFK also inactivated 
phosphorylase in heart extracts (fig.l) but ~24 mg 
was required to inactivate all of the phosphorylase in 
100/al extract. In addition when heart extracts were 
prepared in buffer containing a large excess of exoge- 
nous unlabelled phosphorylase (30 X extract content) 
the radioactivity in band I was reduced to background 
(fig.2). Commercial phosphorylase (Sigma, 30 units/ 
mg) contained no apparent contaminants (fig.2). 
Gel electrophoresis profiles of solubilized immuno- 
precipitates from either control or epinephrine-treated 
Fig.1. Characterization f the antiserum prepared against 
rabbit skeletal muscle PFK. tleart extracts (1:5) from either 
control (e) or epinephrine-treated h arts (o) were prepared as 
in section 2. Supernatants (100 ~1) were added to the indi- 
cated volumes of antiserum (100 mg/ml) and allowed to 
stand at 4°C for 17 h. (A) The immunoprecipitates were col- 
lected by centrifugation for 10 min at 8000 × g, washed 
twice in isotonic saline, solubilized and applied to SDS poly- 
acrylamide gets. Gels were stained (Coomassie brilliant blue) 
and the band corresponding to the subunit of PFK (see fig.2) 
scanned using a densitometer; stimation of the amount of 
protein in this region (insert, a) was made from comparisons 
with known quantities ofPFK applied to separate gels. Cor- 
rections were made for the slight amount of protein in the 
region of the PFK subunit that derived from the antiserum. 
The remaining activity of PFK inthe supernatants follow- 
ing removal of the immunoprecipitates was assayed at 
100 ~M ATP [4] (o,e). Control serum was also tested for its 
ability to inactivate control heart extract PFK (D). (B) The 
remaining activity of phosphorylase in the supernatants fol- 
lowing removal of the immunoprecipitates was assayed [4] 
(A,). Values in (A,B) are for the original 100 **1 heart extract 
supernatant. 
hearts were similar. Three major protein bands were 
apparent. Band I (fig.2) corresponding to the subunit 
of phosphorylase contained 32p radioactivity. Band II 
corresponding to the subunit of PFK contained 14C 
radioactivity corresponding to the S-carboxy p4C]- 
methylated PFK but did not contain any significant 
32p radioactivity. The third band (III) was attribut- 
able to the immunoglobulin subunit. 
In table 1 the effects of a- and 3-adrenergic ago- 
nists on [3Zp]phosphate incorporation i to rat heart 
PFK were examined and compared with the activity 
ratio for the same enzyme. As reported in [ 1 ], activa- 
tion of PFK was mediated by catecholamines possess- 
ing a-adrenergic receptor activity. Thus naphazoline 
and epinephrine treatment led to activation of the 
enzyme but isoproterenol was without effect. Regard- 
less of the agonist used there was no detectable radio- 
activity in the region corresponding to the subunit of 
PFK (band II). As a result of the contaminating phos- 
phorylase in the commercial preparation of PFK, 
radioactively abelled phosphorylase was precipitated 
by the antiserum to PFK. Thus radioactivity was 
detected in band I, corresponding to the subunit of 
phosphorylase. Labelling of this enzyme by [a2p]. 
phosphate was increased by 3-adrenergic agonists. 
The limit of detection was ~5 cpm above back- 
ground (per gel slice). From estimation of the amount 
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of PFK protein in band II and from the determina- 
tion of  the specific radioactivity of  [7-32P] ATP in the 
heart extracts which was 1 8 +- 5.3 cpm/pmol ,  it was 
possible to calculate the extent of  phosphorylat ion of  
PFK that could be detected. On average ach gel con- 
tained 8.5/ag endogenous PFK protein in band II. 
Fig.2. SDS-Polyacrylamide g ls of commercial rabbit skele- 
tal muscle PFK (1), antiserum of PFK (2), solubilized immu- 
noprecipitate from control heart extract (3), solubilized 
immunoprecipitate from epinephrine-treated h art extract o 
which 1 ~g S-carboxy[14C]methylated-PFK had been added 
before mixing with antiserum (4), and rabbit skeletal muscle 
phosphorylase a (Sigma) (5). The gels (10 cm) were run from 
left to right, stained with Coomassie brilliant blue and scanned 
using a densitometer. Sections of the gels between 2-5.5 cm 
have been cut for scanning and photography. Bands ( I - l iD 
correspond to the subunits of phosphorylase, PFK and immu- 
noglobulin, respectively. (A) Gel 3 (o) and gel 4 (e) derived 
from [32P]phosphate-perfused control and epinephrine- 
treated hearts, respectively, were sliced into 1.6 mm sections 
and counted [17] for 32p. Since gel 4 also contained exoge- 
nous S-carboxy [14C] methylated-PFK, slices were counted for 
'4C to locate the PFK subunit. (B) 32p Radioactivity from 
two additional gels is shown: (n) solubilized immunoprecipi- 
tate from epinephrine-treated, [ 32 p] phosphate-perfused h art 
extract; (A) solubilized immunoprecipitate from the same 
epinephrine-treated [ 32p] phosphate-perfused heart extract 
that had been prepared in the presence of 500 t~g exogenous 
phosphorylase a. Experimental details are in section 2 or fig.1. 
Thus phosphorylat ion to the extent of  0.02 mol /mol  
enzyme (360 000 Mr) (10 cpm above background) 
would have been detected. Similar calculations applied 
to phosphorylase and using protein estimations from 
densitometric scans and the determined specific radio- 
activity of  [7-32P] ATP indicated that epinephrine 
increased the phosphorylat ion from 0 .27-0 .53  tool/ 
tool enzyme subunit (94 000 Mr). 
Table 1 
Effect of a- and/3-adrenergic agonists on [32p]phosphate 
incorporation i to rat heart phosphofructokinase 
Additions to Net radioactivity in gel Activity ratio 
perfusate (cpm) a of extract PFK 
(10-SM) 
Phosphorylase PFK 
(band I) (band II) 
None 262 2 (2) 0.21 -+ 0.01 (4) 
Naphazoline 150 7 (2) 0.42 ± 0.02 (3) 
Epinephrine 515 1 (4) 0.60 -+ 0.10 (3) 
Isoproterenol 611 16 (1) 0.24 ± 0.04 (3) 
a The limit of detection was 5 cpm above background 
Experimental conditions were as in fig.2 and the text. Mean 
values are shown. Where appropriate SEM have been calcu- 
lated with no. perfusions in parentheses 
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4. Discussion 
Evidence has accumulated from other laboratories 
to indicate that muscle PFK is phosphorylated both 
in vivo [10,11] and in vitro [12]. Although most 
reports acknowledge that the extent of phosphoryla- 
tion does not alter the catalytic or regulatory proper- 
ties of the skeletal muscle enzyme (e.g., [11 ]), in 
[13,14] the liver enzyme was altered following phos- 
phorylation and in [ 15] skeletal muscle enzyme was 
affected. There have been no reports describing the 
phosphorylation f the heart enzyme in vivo. These 
findings uggest that c~-adrenergic-mediated ctivation 
of heart PFK does not involve phosphorylation f the 
enzyme. The sensitivity of the technique involving 
SDS-polyacrylamide g l electrophoresis of immuno- 
precipitates permitted the detection of changes in 
phosphate content of the order of 0.02 mol/mol tet- 
ramer. Since values for the phosphorylation f phos- 
phorylase obtained using the same techniques were of 
the order expected [16], it appeared unlikely that 
failure to detect phosphorylation f PFK resulted 
from extract phosphatase activity. 
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